Hojjatollah Nozad Charoudeh | Immunotherapy | Best Researcher Award
Assoc. Prof. Dr Hojjatollah Nozad Charoudeh, Scientific Center of Zoology and Hydroecology, Armenia
Assoc. Prof. Dr. Hojjatollah Nozad Charoudeh is a distinguished expert in anatomy, stem cell biology, and immunotherapy ๐งฌ๐งซ. He holds a Ph.D. from Lund University ๐ธ๐ช and completed postdoctoral research at Basel University ๐จ๐ญ. He has served as Head of the Stem Cell Research Centre in Tabriz and currently works at the Scientific Center of Zoology and Hydroecology in Armenia ๐ฆ๐ฒ. His research focuses on NK cells, leukemia, breast cancer, and telomere-mitochondria inhibition ๐ฌ๐. A prolific mentor and editor ๐, heโs received multiple grants and awards ๐ . His impactful work appears in top journals like Human Immunology and BioImpacts .
Publication Profile
Educationย
Assoc. Prof. Dr. Hojjatollah Nozad Charoudeh holds an impressive academic background in biomedical sciences and physiotherapy ๐งฌ๐ง . He completed his postdoctoral research in immunotherapy at the Biomedicine Department of Basel University, Switzerland (2010โ2011) ๐จ๐ญ. Prior to that, he earned his Ph.D. at the Stem Cell Center, Lund University, Sweden (2006โ2010) ๐ธ๐ช. His foundational medical education began in Iran, where he received an M.Sc. in Anatomy (1994โ1997) and a B.Sc. in Physiotherapy (1988โ1992) from Jundishapur University of Medical Sciences ๐ฅ๐. His journey reflects a strong commitment to advancing medical knowledge and patient care globally ๐๐.
Experience
Assoc. Prof. Dr. Hojjatollah Nozad Charoudeh is a distinguished academic with a rich background in anatomical sciences and stem cell biology ๐งฌ๐งโ๐ซ. Since 2025, he has been affiliated with the Scientific Center of Zoology and Hydroecology, NAS RA in Yerevan, Armenia ๐ฆ๐ฒ. From 2015 to 2023, he served as an Associate Professor in the Anatomical Sciences Department, and from 2014 to 2017, he led the Stem Cell Research Centre at Tabriz University of Medical Sciences ๐ฎ๐ท. His earlier roles include Assistant Professor (2012โ2015) and Instructor (1998โ2005). He is also an Associate Editor of Advanced Pharmaceutical Bulletin ๐๐ฌ.
Thesis and Grants
Assoc. Prof. Dr. Hojjatollah Nozad Charoudeh has led extensive research in immunotherapy and stem cell biology ๐ฑ๐งฌ. His work focuses on KIRโบ NK cells from cord blood for cancer and leukemia treatment ๐งซ๐ฏ, exploring telomere and mitochondrial inhibition in leukemia and breast cancer stem cells ๐ฌ๐ฅ. He has supervised numerous Ph.D. and Master’s students ๐ฉโ๐๐จโ๐ across projects on PI3K/AKT signaling, NF-ฮบB, TDT, and liver cell apoptosis pathways ๐ง โ๏ธ. His studies highlight the potential of CD34โบ stem cells and gene regulation in immune therapies ๐๐งช, contributing significantly to translational medicine and cancer immunotherapy advancements ๐๐ฅ.
Awards
Assoc. Prof. Dr. Hojjatollah Nozad Charoudeh has built a distinguished academic career with numerous international and national achievements. He was awarded a Ph.D. scholarship by the Iranian Ministry of Health in 2006 ๐๐ฎ๐ท and later received a six-month scientific grant at Lund University in 2009 ๐๐ฌ. In 2010, he pursued postdoctoral research in the Immunotherapy Department at Basel University, Switzerland ๐งช๐จ๐ญ. He secured a research fund from Tabriz University of Medical Sciences in 2012 ๐ผ๐ and received a prestigious EMBO short scholarship grant in 2013 ๐งฌ๐. His journey reflects dedication to scientific excellence and global collaboration ๐ค๐.
Research Focus
Assoc. Prof. Dr. Hojjatollah Nozad Charoudehโs research primarily focuses on cancer biology, particularly the mechanisms of apoptosis and targeted therapies in hematologic and solid tumors. ๐งฌ His work explores how natural killer (NK) cells, telomerase inhibition, and mitochondrial targeting induce apoptosis in acute myeloid leukemia and breast cancer cells. ๐ฌ He also investigates histone deacetylase inhibitors and the role of Vitamin C in modulating cancer stem cell behavior under hypoxic conditions. ๐ His multidisciplinary approach bridges immunotherapy, molecular oncology, and drug design, aiming to enhance therapeutic efficacy and combat cancer resistance. ๐งซ๐งช๐ง His studies integrate biochemistry, pharmacology, and cellular biology. ๐๐ง